SCYNEXIS (SCYX) Competitors $0.71 +0.00 (+0.37%) Closing price 04:00 PM EasternExtended Trading$0.71 +0.00 (+0.37%) As of 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SCYX vs. BHST, GNLX, TARA, ATOS, HURA, PROC, CCCC, ANIX, MIST, and MCRBShould you be buying SCYNEXIS stock or one of its competitors? The main competitors of SCYNEXIS include BioHarvest Sciences (BHST), Genelux (GNLX), Protara Therapeutics (TARA), Atossa Genetics (ATOS), TuHURA Biosciences (HURA), Procaps Group (PROC), C4 Therapeutics (CCCC), Anixa Biosciences (ANIX), Milestone Pharmaceuticals (MIST), and Seres Therapeutics (MCRB). These companies are all part of the "pharmaceutical products" industry. SCYNEXIS vs. Its Competitors BioHarvest Sciences Genelux Protara Therapeutics Atossa Genetics TuHURA Biosciences Procaps Group C4 Therapeutics Anixa Biosciences Milestone Pharmaceuticals Seres Therapeutics BioHarvest Sciences (NASDAQ:BHST) and SCYNEXIS (NASDAQ:SCYX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk, dividends and media sentiment. Is BHST or SCYX more profitable? BioHarvest Sciences has a net margin of -31.30% compared to SCYNEXIS's net margin of -1,030.04%. SCYNEXIS's return on equity of -53.47% beat BioHarvest Sciences' return on equity.Company Net Margins Return on Equity Return on Assets BioHarvest Sciences-31.30% -307.04% -33.21% SCYNEXIS -1,030.04%-53.47%-32.86% Do institutionals & insiders hold more shares of BHST or SCYX? 54.4% of SCYNEXIS shares are owned by institutional investors. 4.9% of SCYNEXIS shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media prefer BHST or SCYX? In the previous week, BioHarvest Sciences had 2 more articles in the media than SCYNEXIS. MarketBeat recorded 2 mentions for BioHarvest Sciences and 0 mentions for SCYNEXIS. BioHarvest Sciences' average media sentiment score of 0.78 beat SCYNEXIS's score of 0.00 indicating that BioHarvest Sciences is being referred to more favorably in the media. Company Overall Sentiment BioHarvest Sciences Positive SCYNEXIS Neutral Which has more risk and volatility, BHST or SCYX? BioHarvest Sciences has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500. Comparatively, SCYNEXIS has a beta of 1.57, suggesting that its stock price is 57% more volatile than the S&P 500. Which has higher earnings and valuation, BHST or SCYX? BioHarvest Sciences has higher revenue and earnings than SCYNEXIS. BioHarvest Sciences is trading at a lower price-to-earnings ratio than SCYNEXIS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioHarvest Sciences$25.19M4.65-$12.91M-$0.50-14.28SCYNEXIS$3.75M7.39-$21.29M-$0.56-1.27 Do analysts rate BHST or SCYX? BioHarvest Sciences currently has a consensus target price of $13.67, suggesting a potential upside of 91.41%. Given BioHarvest Sciences' stronger consensus rating and higher probable upside, analysts clearly believe BioHarvest Sciences is more favorable than SCYNEXIS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioHarvest Sciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00SCYNEXIS 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryBioHarvest Sciences beats SCYNEXIS on 9 of the 16 factors compared between the two stocks. Get SCYNEXIS News Delivered to You Automatically Sign up to receive the latest news and ratings for SCYX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SCYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCYX vs. The Competition Export to ExcelMetricSCYNEXISMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$27.62M$2.39B$5.47B$8.95BDividend YieldN/A1.80%5.25%4.06%P/E Ratio-1.278.9827.0020.10Price / Sales7.39729.50435.75120.29Price / CashN/A159.8036.8257.86Price / Book0.494.517.985.56Net Income-$21.29M$31.26M$3.16B$248.40M7 Day Performance1.34%5.57%3.69%6.04%1 Month Performance-22.61%5.48%2.91%7.69%1 Year Performance-63.00%1.14%34.30%20.97% SCYNEXIS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCYXSCYNEXIS0.258 of 5 stars$0.71+0.4%N/A-62.1%$27.62M$3.75M-1.2760BHSTBioHarvest SciencesN/A$7.06+2.3%$13.67+93.6%N/A$113.33M$27.70M-14.12N/AHigh Trading VolumeGNLXGenelux1.9715 of 5 stars$2.90-2.7%$17.75+512.1%+46.5%$112.45MN/A-3.3010News CoverageTARAProtara Therapeutics1.6764 of 5 stars$2.80-3.1%$20.50+632.1%+35.3%$111.50MN/A-1.6330ATOSAtossa Genetics1.5909 of 5 stars$0.85-0.4%$6.17+629.1%-22.4%$109.68MN/A-4.038HURATuHURA Biosciences1.2264 of 5 stars$2.40-3.2%$12.67+427.8%N/A$108.33MN/A0.00N/APROCProcaps GroupN/A$0.95-40.3%N/A-62.0%$107.18M$409.92M0.004,900Gap DownHigh Trading VolumeCCCCC4 Therapeutics1.4411 of 5 stars$1.52+2.7%$12.00+689.5%-66.4%$105.09M$35.58M-1.03150ANIXAnixa Biosciences2.644 of 5 stars$3.21-0.6%$9.00+180.4%+40.2%$104.04M$210K-8.455MISTMilestone Pharmaceuticals3.0442 of 5 stars$2.17+11.9%$7.00+222.6%+63.2%$103.72M$1M-2.7830News CoverageGap UpHigh Trading VolumeMCRBSeres Therapeutics3.5404 of 5 stars$10.85-8.6%$73.67+579.0%-33.2%$103.65M$126.32M-2.36330Positive News Related Companies and Tools Related Companies BHST Alternatives GNLX Alternatives TARA Alternatives ATOS Alternatives HURA Alternatives PROC Alternatives CCCC Alternatives ANIX Alternatives MIST Alternatives MCRB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SCYX) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored$3,200 from your phone?No charts. No crypto. No stock picking. With just a regular brokerage app and Jeff Clark’s “Crossfire” meth...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SCYNEXIS, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SCYNEXIS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SCYX Stock Alerts